trending Market Intelligence /marketintelligence/en/news-insights/trending/dzvmlbTlbYSKQ-IB6y205g2 content esgSubNav
In This List

Novelion Therapeutics appoints CFO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Novelion Therapeutics appoints CFO

Novelion Therapeutics Inc. appointed Michael Price as CFO and senior vice president, effective Dec. 4.

Price joins Novelion from Noven Pharmaceuticals Inc., where he served as vice president and CFO.

Gregory Perry has resigned as CFO of Novelion to pursue other opportunities, and will remain with the company until Dec. 31 to enable an effective transition.